Women's health Clinical Trials in Aurora, CO
As of July 2026, 59 paid clinical trials are recruiting for Women's health in Aurora, Colorado. Recruiting Women's health studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
59 clinical trials for Women's health
·Clear filters·↓ Download CSVA Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Contraceptive Efficacy Study of Ovaprene
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
A Study of NX-1607 in Adults With Advanced Malignancies
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mobile Health for Adherence in Breast Cancer Patients
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
E-Mindfulness Approaches for Living After Breast Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Improving Care for Rural Patients With Solid Tumors
Long Term Evaluation of Scapular-inserted Contraceptive Implants
Menopausal HT for Women Living With HIV (HoT)
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
About research studies in Aurora
Aurora has approximately 1,101 recruiting research studies across a wide range of therapeutic areas. Colorado hosts the University of Colorado Anschutz Medical Campus, National Jewish Health, and Children's Hospital Colorado, with strong programs in pulmonology, oncology, and cardiovascular research.
Top Research Study Locations in Aurora
Researchers run research studies in Aurora, CO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Children's Hospital Colorado | High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Acute Myeloid Leukemia | 182 |
| University of Colorado Anschutz Medical Campus | Obesity, Cannabis Use Disorder, Overweight and Obesity | 108 |
| University of Colorado | Parkinson Disease, Acute Myeloid Leukemia, Barrett Esophagus | 90 |
| UCHealth University of Colorado Hospital | Metastatic Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 55 |
| University of Colorado Hospital | Acute Kidney Injury, Carcinoma, Non-Small-Cell Lung, Lung Cancer | 55 |
| University of Colorado Cancer Center | Breast Cancer, Advanced Solid Tumor, Melanoma | 36 |
| University of Colorado Denver | Contraception, Depression, Anxiety, Diabetes | 32 |
| Rocky Mountain Regional VA Medical Center, Aurora, CO | Aging, Chronic Obstructive Pulmonary Disease, Chronic Pain | 31 |
| Rocky Mountain Cancer Centers-Aurora | Malignant Solid Neoplasm, Melanoma, Anatomic Stage IV Breast Cancer AJCC v8 | 24 |
| University of Colorado Anschutz | Acanthamoeba Keratitis, Adiposity, Alcohol Use Disorder | 21 |
| Childrens Hospital Colorado | Hypochondroplasia, Adolescent Obesity, Anger | 17 |
| Rocky Mountain Regional VA Medical Center | Hypertension, Malignant Solid Neoplasm, Melanoma | 15 |
| Children's Hospital of Colorado | Cystic Fibrosis, Muscular Atrophy, Spinal, Abnormal Glucose Tolerance | 14 |
| The Medical Center of Aurora | Chronic Lymphocytic Leukemia, Malignant Solid Neoplasm, Melanoma | 12 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Irritable Bowel Syndrome | 10 |
| University of Colorado - Anschutz Medical Campus | Aging, Hypertension, Interstitial Lung Disease | 10 |
| Rocky Mountain Cancer Centers | Breast Cancer, Higher-risk Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | 9 |
| University of Colorado School of Medicine | Cervical Cancer, Choline Deficiency, Diffuse Large B Cell Lymphoma (DLBCL) | 7 |
| University of Colorado, Denver | Arrhythmogenic Right Ventricular Cardiomyopathy, Arteriovenous Malformations, Cannabis Smoking | 6 |
| Rocky Mountain Cancer Centers, LLP | Colorectal Neoplasms, Advanced/Metastatic Urothelial Cancer, B-Cell Non-Hodgkins Lymphoma | 6 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 5 |
| Colorado Children's Hospital | Anesthesia, Caregiver Stress, Children | 5 |
| University of Colorado Denver Anschutz Medical Campus | IUGR, Pregnancy, Frostbite | 5 |
| University of Colorado Hospital - Anschutz Cancer Pavilion | Advanced Liver Cancers, Advanced Melanoma, Advanced Or Metastatic Merkel Cell Carcinoma | 5 |
| University of Colorado, Anschutz Medical Campus | Advanced Melanoma, Amputation, Bone Anchored Devices | 5 |
Active & Upcoming Studies in Aurora (2026)
Recruiting trials in Aurora grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (313 active studies)
- Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment · University of Colorado, Denver
- Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma · Phase 2 · University of Colorado, Denver
Diabetes & metabolic (87 active studies)
- Digitally Enhanced Cognitive-Behavioral Therapy · Colorado State University
- PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study · Phase 3 · University of Florida
Neurology & pain (70 active studies)
- Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care · Phase 1 · VA Office of Research and Development
- Headache Education and Awareness vs. Daily Mindfulness Strategies - Understanding Pain · University of Colorado, Denver
Cardiovascular (63 active studies)
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
- Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH) · Phase 2 · Stanford University
Pediatric (33 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- Asthma Ctrl SMART Trial · Children's Hospital Medical Center, Cincinnati
Mental health & behavior (20 active studies)
- Digitally Enhanced Cognitive-Behavioral Therapy · Colorado State University
- Multi-Site Trial of Tirzepatide for Smoking Cessation · Phase 2 · University of Southern California
HIV / STI (16 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
Vaccines (8 active studies)
Eye & vision (5 active studies)
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma · Phase 3 · AbbVie
- A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) · Phase 1, Phase 2 · Splice Bio
Common conditions studied in Aurora
- Breast Cancer (22 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Obesity (18 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Heart Failure (13 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Melanoma (13 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
- Colorectal Cancer (12 active studies). Colorectal cancer trials explore novel chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors.
- Type 1 Diabetes (12 active studies). Type 1 diabetes research investigates immune-modulating therapies, stem cell–derived islet replacement, and closed-loop insulin delivery systems.
Leading research sponsors in Aurora
- University of Colorado, Denver
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
- AstraZeneca
Local regulations and guidelines
Clinical trials in Colorado are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Colorado trials are additionally subject to the Colorado Privacy Act (CPA), which adds consumer data-protection requirements to federal baseline standards.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Aurora. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Aurora
Hipa.ai aggregates every recruiting study in Aurora from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Aurora?
There are approximately 1,101 recruiting clinical trials in Aurora, Colorado listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Aurora pay participants?
Most recruiting trials in Aurora compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Aurora?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Aurora?
The most common conditions under active study in Aurora include Breast Cancer (22), Obesity (18), Heart Failure (13), Melanoma (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Aurora?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Aurora on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Aurora?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Aurora?
Recruiting research sites in Aurora include Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, University of Colorado, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Aurora right now?
The largest active categories in Aurora are Cancer & tumors (313), Diabetes & metabolic (87), Neurology & pain (70). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.